<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) has been identified in China as"/>
 <result pre="market, where there was witnessed a wave of noteworthy suspected" exact="pneumonia" post="disease that began with progressive respiratory failure due to"/>
 <result pre="wave of noteworthy suspected pneumonia disease that began with progressive" exact="respiratory failure" post="due to alveolar damage and even death. Successively, this"/>
 <result pre="for the modulation of the immune response in infectious and" exact="autoimmune disease" post="[25,26]. In particular, the active form of vitamin D,"/>
 <result pre="trials reported that vitamin C decreased the duration of the" exact="common cold" post="by 8% in adults and 14% in children [40]."/>
 <result pre="its pharmacological activities with applications in several therapeutic areas, including" exact="cancer" post="[101,102,103]. The antiviral activity of berberine against influenza and"/>
 <result pre="areas, including cancer [101,102,103]. The antiviral activity of berberine against" exact="influenza" post="and alphaviruses has been described [104]. In the SARS-CoV-2"/>
 <result pre="authors declare no conflict of interest. References References 1.ZhouP.YangX.-L.WangX.-G.HuB.ZhangL.ZhangW.SiH.-R.ZhuY.LiB.HuangC.-L.et al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="severity is increased in vitamin D deficiencyFront. Public Health2020851310.3389/fpubh.2020.0051333014983 24.CannellJ.J.ViethR.UmhauJ.C.HolickM.F.GrantW.B.MadronichS.GarlandC.F.GiovannucciE.Epidemic" exact="influenza" post="and vitamin DEpidemiol. Infect.20061341129114010.1017/S095026880600717516959053 25.BracaleR.VaccaroC.M.ColettaV.CricelliC.GamaleriF.C.ParazziniF.CarrubaM.Nutrition behaviour and compliance with"/>
 <result pre="multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human" exact="cancer" post="cellsPhytomedicine2014211110111910.1016/j.phymed.2014.04.02924856768 85.LanJ.HuangL.LouH.ChenC.LiuT.HuS.YaoY.SongJ.LuoJ.LiuY.et al.Design and synthesis of novel C14-urea-tetrandrine derivatives"/>
 <result pre="in a single-centre cohort of adult hospitalised patients with COVID-19" exact="pneumonia" post="and acute respiratory distress syndromeAnn. Rheum. Dis.2020791286128910.1136/annrheumdis-2020-21771232732245 100.GendelmanO.AmitalH.BragazziN.L.WatadA.ChodickG.Continuous hydroxychloroquine"/>
 <result pre="Model.20165648450010.1021/acs.jcim.5b0065826841201 104.VargheseF.S.KaukinenP.GlÃ¤skerS.BespalovM.HanskiL.WennerbergK.KÃ¼mmererB.M.AholaT.Discovery of berberine, abamectin and ivermectin as antivirals against" exact="chikungunya" post="and other alphavirusesAntivir. Res.201612611712410.1016/j.antiviral.2015.12.01226752081 105.PizzornoA.PadeyB.DuboisJ.JulienT.TraversierA.DuliÃ¨reV.BrunP.LinaB.Rosa-CalatravaM.TerrierO.In vitro evaluation of antiviral"/>
 <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci. Trends202014727310.5582/bst.2020.0104732074550 169.MahevasM.TranV.-T.RoumierM.ChabrolA.PauleR.GuillaudC.GallienS.LepeuleR.SzwebelT.-A.LescureX.No evidence of clinical efficacy"/>
</results>
